In contrast, knockdown of ALYREF inhibited the elevation of EZH2 expression triggered by NOP2 overexpression as well as the enhancement of the migratory invasive ability of lung cancer cells (Fig. S2A–E). The gene discussed is NOP2; the disease is lung carcinoma.